|
|||||
|
|

Insurance provider CNA Financial (NYSE:CNA) met Wall Streets revenue expectations in Q3 CY2025, with sales up 5.5% year on year to $3.82 billion. Its non-GAAP profit of $1.50 per share was 13.6% above analysts’ consensus estimates.
Is now the time to buy CNA? Find out in our full research report (it’s free for active Edge members).
CNA Financial’s third quarter results were marked by robust underwriting gains and improved net investment income, both highlighted by management as core contributors to profitability. CEO Douglas Worman pointed to a "record core income of $409 million, driven by very strong underwriting gain and higher net investment income." Management emphasized that lower catastrophe losses and continued expense control supported the quarter, with underwriting income nearly tripling year over year. Despite some caution on loss cost trends and pockets of competitive pricing pressure, CNA’s disciplined approach to portfolio optimization and risk selection underpinned the solid outcome.
Looking ahead, CNA’s guidance reflects measured optimism, with management focusing on maintaining underwriting discipline amid evolving market conditions and leveraging technology, including artificial intelligence, to drive efficiency. Worman stated, “We are managing our expense ratio effectively while continuing to increase our investment in talent and technology.” The company believes that ongoing opportunities in the excess and surplus lines market will be a key growth lever, while proactive management of long-term care reserves and investment portfolio actions are expected to support financial stability. Management also underscored the importance of adapting to market dynamics by expanding in profitable segments and retrenching where pricing is inadequate.
CNA’s solid third quarter was shaped by strong underwriting performance, effective expense management, and strategic portfolio adjustments in response to market trends.
CNA expects continued profitability to be supported by underwriting discipline, expansion in selected markets, and ongoing investment in technology, while remaining vigilant about loss trends and competitive pressures.
In the coming quarters, the StockStory team will be closely watching (1) the pace of premium growth in excess and surplus lines as CNA seeks to expand its Cardinal E&S offering, (2) the company’s ability to maintain or further reduce the expense ratio amid ongoing investments in technology, and (3) how effectively management navigates loss cost trends and competitive pressure, particularly in commercial auto and specialty lines. The impact of long-term care reserve management and investment portfolio performance will also be key areas to monitor.
CNA Financial currently trades at $46.89, up from $44.55 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| Dec-15 | |
| Dec-11 | |
| Dec-04 | |
| Dec-03 | |
| Dec-03 | |
| Nov-28 | |
| Nov-27 | |
| Nov-25 | |
| Nov-21 | |
| Nov-18 | |
| Nov-12 | |
| Nov-11 | |
| Nov-07 | |
| Nov-06 | |
| Nov-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite